NCT00264004View on ClinicalTrials.gov

Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours

PHASE2CompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

April 30, 2011

Conditions

Tumors

Interventions

DRUG

AZD2171

30 mg \& 45 mg oral tablet

Trial Locations (6)

Unknown

Research Site, Freiburg im Breisgau

Research Site, Hamburg

Research Site, Amsterdam

Research Site, Nijmegen

Research Site, Utrecht

Research Site, Surrey

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY